Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- ReGenTree, LLC
- Study ID
- NCT03937882
- Phase
- PHASE3
- Status
- Completed
Conditions
- Dry Eye
- Dry Eye Syndromes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- RGN-259 — DRUGA preservative-free, sterile eye drop solution containing Thymosin beta 4 for direct instillation into each eye, four times a day (QID) for 14 days
- Placebo — DRUGIt is composed of the same excipients as RGN-259 but does not contain Thymosin beta 4
Study Details
The objective of this study is to compare the safety and efficacy of RGN-259 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Key Dates
- Start date
- May 24, 2019
- Status verified
- Nov 2021
- Primary completion
- Nov 8, 2020
- Completion
- Oct 7, 2021
Study Design
- Enrollment
- 700 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RGN-259RGN-259: It is a preservative-free, sterile eye drop solution containing Thymosin beta 4
- Placebo Comparator: PlaceboIt is composed of the same excipients as RGN-259 but does not contain Thymosin beta 4
Primary Outcome Measure
Corneal staining [ Time Frame: 15 days after first dosing ]
Locations (20)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cornea and Cataract Consultants of Arizona | Phoenix | Arizona | 85032 | - |
| Eye Research Foundation | Newport Beach | California | 92663 | - |
| Vision Institute | Colorado Springs | Colorado | 80907 | - |
| Dovilan Wyatt MD, LLC | Chicago | Illinois | 60619 | - |
| Midwest Cornea Associates, LLC | Indianapolis | Indiana | 46290 | - |
| Whitson Vision | Indianapolis | Indiana | 46240 | - |
| The Eye Care Institute | Louisville | Kentucky | 40206 | - |
| Andover Eye Associates | Andover | Massachusetts | 01810 | - |
| Andover Eye Associates | Raynham | Massachusetts | 02767 | - |
| Center For Sight | Henderson | Nevada | 89052 | - |
| Oculus Research, Inc. at the Eye Care Center | Raleigh | North Carolina | 27603 | - |
| Visual Eyes Optometric | Shelby | North Carolina | 28150 | - |
| Bergstrom Eye Research, LLC | Fargo | North Dakota | 58103 | - |
| Scott & Christie and Associates, PC | Cranberry Township | Pennsylvania | 16066 | - |
| Andover Eye Associates | Warwick | Rhode Island | 02886 | - |
| Total Eye Care, P.A. | Memphis | Tennessee | 38119 | - |
| Texan Eye/Keystone Research | Austin | Texas | 78731 | - |
| Mountain View Eye Center | Layton | Utah | 84041 | - |
| Country Hills Eye Center | Ogden | Utah | 84403 | - |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Penn SICCA Follow-up StudyNot Yet Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune DiseasePHASE4 · Recruiting · Toyos Clinic · Nashville, Tennessee
- Quality of Life in Presbyopic Patients Who Are Treated With QlosiPHASE4 · Recruiting · Southern College of Optometry · Medina, Minnesota
- Low Level Light Therapy & Skin PigmentationRecruiting · University of Houston · Houston, Texas